RSS feed

Publications (original articles or review articles) published in 2014 from OUS - Department of Urology

29 publications found

Ahmed HU, Berge V, Bottomley D, Cross W, Heer R, Kaplan R, Leslie T, Parker C, Relton C, Stephens R, Sydes MR, Turnbull L, van der Meulen J, Vickers A, Wilt T, Emberton M, Prostate Cancer RCT Consensus Group (2014)
Can we deliver randomized trials of focal therapy in prostate cancer?
Nat Rev Clin Oncol, 11 (8), 482-91
DOI 10.1038/nrclinonc.2014.44, PubMed 24751803

Andreassen OA, Zuber V, Thompson WK, Schork AJ, Bettella F, PRACTICAL Consortium, CRUK GWAS, Djurovic S, Desikan RS, Mills IG, Dale AM (2014)
Shared common variants in prostate cancer and blood lipids
Int J Epidemiol, 43 (4), 1205-14
DOI 10.1093/ije/dyu090, PubMed 24786909

Baco E, Gelet A, Crouzet S, Rud E, Rouvière O, Tonoli-Catez H, Berge V, Chapelon JY, Eggesbø HB (2014)
Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study
BJU Int, 114 (4), 532-40
DOI 10.1111/bju.12545, PubMed 24930692

Baco E, Ukimura O, Rud E, Vlatkovic L, Svindland A, Aron M, Palmer S, Matsugasumi T, Marien A, Bernhard JC, Rewcastle JC, Eggesbø HB, Gill IS (2014)
Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients
Eur Urol, 67 (4), 787-94
DOI 10.1016/j.eururo.2014.08.077, PubMed 25240973

Bancroft EK, Page EC, Castro E, Lilja H, Vickers A, Sjoberg D, Assel M, Foster CS, Mitchell G, Drew K, Mæhle L, Axcrona K, Evans DG, Bulman B, Eccles D, McBride D, van Asperen C, Vasen H, Kiemeney LA, Ringelberg J, Cybulski C, Wokolorczyk D, Selkirk C, Hulick PJ, Bojesen A et al. (2014)
Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study
Eur Urol, 66 (3), 489-99
DOI 10.1016/j.eururo.2014.01.003, PubMed 24484606

Barfeld SJ, Itkonen HM, Urbanucci A, Mills IG (2014)
Androgen-regulated metabolism and biosynthesis in prostate cancer
Endocr Relat Cancer, 21 (4), T57-66
DOI 10.1530/ERC-13-0515, PubMed 24497572

Bon H, Wadhwa K, Schreiner A, Osborne M, Carroll T, Ramos-Montoya A, Ross-Adams H, Visser M, Hoffmann R, Ahmed AA, Neal DE, Mills IG (2014)
Salt-inducible kinase 2 regulates mitotic progression and transcription in prostate cancer
Mol Cancer Res, 13 (4), 620-635
DOI 10.1158/1541-7786.MCR-13-0182-T, PubMed 25548099

Dahl S, Loge JH, Berge V, Dahl AA, Cvancarova M, Fosså SD (2014)
Influence of radical prostatectomy for prostate cancer on work status and working life 3 years after surgery
J Cancer Surviv, 9 (2), 172-9
DOI 10.1007/s11764-014-0399-6, PubMed 25216609

Donaldson IA, Alonzi R, Barratt D, Barret E, Berge V, Bott S, Bottomley D, Eggener S, Ehdaie B, Emberton M, Hindley R, Leslie T, Miners A, McCartan N, Moore CM, Pinto P, Polascik TJ, Simmons L, van der Meulen J, Villers A, Willis S, Ahmed HU (2014)
Focal therapy: patients, interventions, and outcomes--a report from a consensus meeting
Eur Urol, 67 (4), 771-7
DOI 10.1016/j.eururo.2014.09.018, PubMed 25281389

Engedal N, Mills IG (2014)
Endosomal signaling and oncogenesis
Methods Enzymol, 535, 179-200
DOI 10.1016/B978-0-12-397925-4.00012-2, PubMed 24377925

Holm HV, Fosså SD, Hedlund H, Schultz A, Dahl AA (2014)
How should continence and incontinence after radical prostatectomy be evaluated? A prospective study of patient ratings and changes with time
J Urol, 192 (4), 1155-61
DOI 10.1016/j.juro.2014.03.113, PubMed 24727062

Holm HV, Fosså SD, Hedlund H, Schultz A, Dahl AA (2014)
Severe postprostatectomy incontinence: Is there an association between preoperative urodynamic findings and outcome of incontinence surgery?
Scand J Urol, 49 (3), 250-9
DOI 10.3109/21681805.2014.980845, PubMed 25428752

Itkonen HM, Engedal N, Babaie E, Luhr M, Guldvik IJ, Minner S, Hohloch J, Tsourlakis MC, Schlomm T, Mills IG (2014)
UAP1 is overexpressed in prostate cancer and is protective against inhibitors of N-linked glycosylation
Oncogene, 34 (28), 3744-50
DOI 10.1038/onc.2014.307, PubMed 25241896

Mills IG (2014)
Maintaining and reprogramming genomic androgen receptor activity in prostate cancer
Nat Rev Cancer, 14 (3), 187-98
DOI 10.1038/nrc3678, PubMed 24561445

Nilsson R, Omland H, Dahl AA, Johansen TE (2014)
Early outcome of orchiopexy and analysis of predictive factors: a retrospective study from 2001 to 2010 in a Norwegian regional hospital
Scand J Urol, 48 (5), 474-81
DOI 10.3109/21681805.2014.905631, PubMed 24720831

Ragnum HB, Vlatkovic L, Lie AK, Axcrona K, Julin CH, Frikstad KM, Hole KH, Seierstad T, Lyng H (2014)
The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer
Br J Cancer, 112 (2), 382-90
DOI 10.1038/bjc.2014.604, PubMed 25461803

Ramos-Montoya A, Lamb AD, Russell R, Carroll T, Jurmeister S, Galeano-Dalmau N, Massie CE, Boren J, Bon H, Theodorou V, Vias M, Shaw GL, Sharma NL, Ross-Adams H, Scott HE, Vowler SL, Howat WJ, Warren AY, Wooster RF, Mills IG, Neal DE (2014)
HES6 drives a critical AR transcriptional programme to induce castration-resistant prostate cancer through activation of an E2F1-mediated cell cycle network
EMBO Mol Med, 6 (5), 651-61
DOI 10.1002/emmm.201303581, PubMed 24737870

Rud E, Baco E, Lien D, Klotz D, Eggesbø HB (2014)
Detection of radiorecurrent prostate cancer using diffusion-weighted imaging and targeted biopsies
AJR Am J Roentgenol, 202 (3), W241-6
DOI 10.2214/AJR.12.10483, PubMed 24555620

Rud E, Klotz D, Rennesund K, Baco E, Berge V, Lien D, Svindland A, Lundeby E, Berg RE, Eri LM, Eggesbø HB (2014)
Detection of the index tumour and tumour volume in prostate cancer using T2-weighted and diffusion-weighted magnetic resonance imaging (MRI) alone
BJU Int, 114 (6b), E32-E42
DOI 10.1111/bju.12637, PubMed 24447606

Rud E, Klotz D, Rennesund K, Baco E, Johansen TE, Diep LM, Svindland A, Eri LM, Eggesbø HB (2014)
Preoperative magnetic resonance imaging for detecting uni- and bilateral extraprostatic disease in patients with prostate cancer
World J Urol, 33 (7), 1015-21
DOI 10.1007/s00345-014-1362-x, PubMed 25059766

Salji M, Jones R, Paul J, Birrell F, Dixon-Hughes J, Hutchison C, Johansen TE, Greene D, Parr N, Leung HY, Cryotherapy in Prostate Cancer (CROP) study team (2014)
Feasibility study of a randomised controlled trial to compare (deferred) androgen deprivation therapy and cryotherapy in men with localised radiation-recurrent prostate cancer
Br J Cancer, 111 (3), 424-9
DOI 10.1038/bjc.2014.316, PubMed 24946001

Schultz A, Boye B, Jonsson O, Thind P, Månsson W (2014)
Urostomy and health-related quality of life in patients with lower urinary tract dysfunction
Scand J Urol, 49 (1), 2-7
DOI 10.3109/21681805.2013.876095, PubMed 25370732

Servoll E, Sæter T, Vlatkovic L, Nesland JM, Waaler G, Axcrona K (2014)
Prostate-specific antigen doubling time subsequent to radical prostatectomy is a predictor of outcome following salvage external beam radiation therapy: a single-centre experience
Scand J Urol, 49 (3), 218-23
DOI 10.3109/21681805.2014.982168, PubMed 25428750

Servoll E, Vlatkovic L, Sæter T, Nesland JM, Axcrona U, Waaler G, Axcrona K (2014)
The length of a positive surgical margin is of prognostic significance in patients with clinically localized prostate cancer treated with radical prostatectomy
Urol Int, 93 (3), 289-95
DOI 10.1159/000362342, PubMed 25170745

Sharma NL, Massie CE, Butter F, Mann M, Bon H, Ramos-Montoya A, Menon S, Stark R, Lamb AD, Scott HE, Warren AY, Neal DE, Mills IG (2014)
The ETS family member GABPα modulates androgen receptor signalling and mediates an aggressive phenotype in prostate cancer
Nucleic Acids Res, 42 (10), 6256-69
DOI 10.1093/nar/gku281, PubMed 24753418

Siddiqui H, Lagesen K, Nederbragt AJ, Eri LM, Jeansson SL, Jakobsen KS (2014)
Pathogens in Urine from a Female Patient with Overactive Bladder Syndrome Detected by Culture-independent High Throughput Sequencing: A Case Report
Open Microbiol J, 8, 148-53
DOI 10.2174/1874285801408010148, PubMed 25685246

Tandstad T, Ståhl O, Håkansson U, Dahl O, Haugnes HS, Klepp OH, Langberg CW, Laurell A, Oldenburg J, Solberg A, Söderström K, Cavallin-Ståhl E, Stierner U, Wahlquist R, Wall N, Cohn-Cedermark G, SWENOTECA (2014)
One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group
Ann Oncol, 25 (11), 2167-2172
DOI 10.1093/annonc/mdu375, PubMed 25114021

Tenke P, Köves B, Johansen TE (2014)
An update on prevention and treatment of catheter-associated urinary tract infections
Curr Opin Infect Dis, 27 (1), 102-7
DOI 10.1097/QCO.0000000000000031, PubMed 24345923

Wagenlehner FM, Pilatz A, Waliszewski P, Weidner W, Johansen TE (2014)
Reducing infection rates after prostate biopsy
Nat Rev Urol, 11 (2), 80-6
DOI 10.1038/nrurol.2013.322, PubMed 24418806